Orris

Inj ketorpal

Reading File
Ketorolac (Ketoprofen/Ketorolac) injection is an NSAID used for short-term management of moderate-to-severe acute pain. Let me pull the full details from the medical library.
Searching sources...
Finding Sources
Searching the Web

Inj Ketorolac injection uses dose mechanism side effects

Reading File
Reading File
Here is a complete profile of Injection Ketorolac (Toradol):

Injection Ketorolac (Toradol)

Class & Mechanism

Ketorolac is a parenteral NSAID (acetic acid derivative) that provides analgesia by inhibiting COX-1 and COX-2, thereby reducing prostaglandin synthesis. It is primarily a peripherally acting analgesic - it does not cross the blood-brain barrier to any significant degree, which explains its lack of CNS opioid-type side effects.
  • Goodman & Gilman's, p. 281: "Ketorolac is a potent analgesic but only a moderately effective anti-inflammatory drug."

Indications

  • Short-term (≤5 days) management of moderate-to-severe acute pain
  • Postoperative analgesia (opioid-sparing)
  • Post-trauma pain
  • Renal colic, biliary colic
  • Ophthalmic use: seasonal allergic conjunctivitis, postoperative ocular inflammation
  • Fixed-dose combination with phenylephrine: irrigation during cataract/IOL replacement surgery

Routes of Administration

RouteDose
Intramuscular (IM)30-60 mg loading dose
Intravenous (IV)15-30 mg loading dose
Oral (continuation only)10-20 mg
Intranasal31.5 mg
Maintenance: 15-30 mg every 6 hours (IM or IV) Maximum duration: 5 days (parenteral + oral combined)
Pediatric dose (2-16 years):
  • IM: 1 mg/kg (max 30 mg), single dose
  • IV: 0.5 mg/kg (max 15 mg), single dose
Elderly: Reduce dose (slower clearance).

Analgesic Equivalence

A standard dose of ketorolac provides analgesia equivalent to 6-12 mg of morphine by the same route. Onset is similar to morphine, but duration is longer (6-8 hours). It has a significant opioid-sparing effect - reduces postoperative opioid requirements.

Pharmacokinetics

  • Onset: Rapid (similar to morphine)
  • Duration: 6-8 hours
  • Elimination: Renal (do NOT use in kidney disease)
  • Protein binding: High

Side Effects

Common (1-10%):
  • GI: Nausea (>10%), dyspepsia, abdominal pain, GI ulcers/bleeding
  • CNS: Headache (17%), dizziness (7%), somnolence (6%)
  • Injection site pain (2%)
  • Edema, hypertension
Serious:
  • GI ulceration, perforation, bleeding
  • Renal toxicity (papillary necrosis with prolonged use)
  • Platelet inhibition - prolongs bleeding time (COX-1 effect)
  • Hypersensitivity/anaphylaxis
  • Cardiovascular events (MI, stroke)

Contraindications

  • Renal disease (drug is renally eliminated)
  • Aspirin/NSAID allergy
  • Perioperative CABG pain management
  • Routine obstetric analgesia (affects fetal ductus arteriosus)
  • Probenecid co-administration (triples ketorolac AUC, doubles t1/2)
  • Active GI ulceration/bleeding
  • Patients at high risk for postoperative hemorrhage (use with caution)
Caution in asthmatics - ~10% have aspirin sensitivity; higher (~20%) if nasal polyps are also present.

Key Advantages Over Opioids

  • No respiratory depression
  • No sedation
  • No nausea/vomiting from the drug itself
  • No addiction potential
  • Ideal for patients at risk for opioid-related side effects

Drug Interactions

  • Aspirin: Decreases protein binding of ketorolac → increases free (active) drug levels
  • Probenecid: Triples AUC - avoid combination
  • Other NSAIDs: Additive toxicity - avoid
  • Anticoagulants: Additive bleeding risk
  • Does not affect minimum alveolar concentration (MAC) of inhalation agents
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 281-284; Morgan and Mikhail's Clinical Anesthesiology 7e, p. 525-526
This is a shared conversation. Sign in to Orris to start your own chat.